. . . . . . . "[After pooling all the eligible studies, we identified significant associations of GSTP1 Ile105Val polymorphism with chemotherapy-related tumor response (G vs. A: OR 1.697, 95�%�CI 1.191-2.418; GG vs. AA: OR 2.804, 95�%�CI 1.414-5.560; AG vs. AA: OR 1.540, 95�%�CI 1.011-2.347; GG vs. AAAG: OR 2.139, 95�%�CI 1.256-3.641), PFS (GG vs. AA, HR 0.640, 95�%�CI 0.455-0.900; AGGG vs. AA: HR 0.718, 95�%�CI 0.562-0.919), and OS (AG vs. AA: HR 0.857, 95�%�CI 0.746-0.986; GG vs. AA: HR 0.679, 95�%�CI 0.523-0.882; AGGG vs. AA: HR 0.663, 95�%�CI 0.542-0.812) in gastric and colorectal cancers and no significant association was found between the polymorphism with toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:56+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .